Literature DB >> 22441017

LRRK2 as a modulator of lysosomal calcium homeostasis with downstream effects on autophagy.

Patricia Gómez-Suaga1, Sabine Hilfiker.   

Abstract

Alterations in autophagy are thought to underlie various neurodegenerative diseases including Parkinson disease (PD). Previous studies have indicated that the PD gene leucine rich repeat kinase 2 (LRRK2) is involved in this process, but its mechanism of action has remained unknown. Our recent work describes how LRRK2 acts through calcium-mediated events originating from acidic stores to regulate autophagy and cell survival, which may give rise to novel therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22441017     DOI: 10.4161/auto.19305

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  15 in total

1.  The Two-pore channel (TPC) interactome unmasks isoform-specific roles for TPCs in endolysosomal morphology and cell pigmentation.

Authors:  Yaping Lin-Moshier; Michael V Keebler; Robert Hooper; Michael J Boulware; Xiaolong Liu; Dev Churamani; Mary E Abood; Timothy F Walseth; Eugen Brailoiu; Sandip Patel; Jonathan S Marchant
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-25       Impact factor: 11.205

2.  WHOPPA Enables Parallel Assessment of Leucine-Rich Repeat Kinase 2 and Glucocerebrosidase Enzymatic Activity in Parkinson's Disease Monocytes.

Authors:  Rebecca L Wallings; Laura P Hughes; Hannah A Staley; Zachary D Simon; Nikolaus R McFarland; Roy N Alcalay; Alicia Garrido; María José Martí; Eduardo Tolosa Sarró; Nicolas Dzamko; Malú Gámez Tansey
Journal:  Front Cell Neurosci       Date:  2022-06-09       Impact factor: 6.147

3.  Genotype and age at Parkinson disease diagnosis.

Authors:  Susan Searles Nielsen; Theo K Bammler; Lisa G Gallagher; Federico M Farin; Wt Longstreth; Gary M Franklin; Phillip D Swanson; Harvey Checkoway
Journal:  Int J Mol Epidemiol Genet       Date:  2013-03-18

Review 4.  Aberrant autophagy and parkinsonism: does correction rescue from disease progression?

Authors:  Abhishek Kumar Mishra; Mohd Sami ur Rasheed; Saurabh Shukla; Manish Kumar Tripathi; Anubhuti Dixit; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2014-05-16       Impact factor: 5.590

5.  The LRRK2 inhibitor GSK2578215A induces protective autophagy in SH-SY5Y cells: involvement of Drp-1-mediated mitochondrial fission and mitochondrial-derived ROS signaling.

Authors:  S Saez-Atienzar; L Bonet-Ponce; J R Blesa; F J Romero; M P Murphy; J Jordan; M F Galindo
Journal:  Cell Death Dis       Date:  2014-08-14       Impact factor: 8.469

Review 6.  The role of the LRRK2 gene in Parkinsonism.

Authors:  Jie-Qiong Li; Lan Tan; Jin-Tai Yu
Journal:  Mol Neurodegener       Date:  2014-11-12       Impact factor: 14.195

Review 7.  The role of Ca2+ signaling in Parkinson's disease.

Authors:  Sofia V Zaichick; Kaitlyn M McGrath; Gabriela Caraveo
Journal:  Dis Model Mech       Date:  2017-05-01       Impact factor: 5.758

8.  A Link between Autophagy and the Pathophysiology of LRRK2 in Parkinson's Disease.

Authors:  Patricia Gómez-Suaga; Elena Fdez; Marian Blanca Ramírez; Sabine Hilfiker
Journal:  Parkinsons Dis       Date:  2012-12-03

9.  Surfactant secretion in LRRK2 knock-out rats: changes in lamellar body morphology and rate of exocytosis.

Authors:  Pika Miklavc; Konstantin Ehinger; Kristin E Thompson; Nina Hobi; Derya R Shimshek; Manfred Frick
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

Review 10.  Mitochondria: A Therapeutic Target for Parkinson's Disease?

Authors:  Yu Luo; Alan Hoffer; Barry Hoffer; Xin Qi
Journal:  Int J Mol Sci       Date:  2015-09-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.